Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : COB Columbia Laboratories -- Ignore unavailable to you. Want to Upgrade?

To: Emil Veakis who wrote (597)	11/4/1999 11:04:00 PM
From: wolfdog2	Respond to of 634

Emil, thanks for calling my attention to the mention in Forbes. I get Forbes, but missed it. As to the shorts scurrying for cover, I don't think they'll need to worry until it becomes evident that sales to support analysts' earnings' projections will come through. Other news that could move the stock, but I don't think dramatically, includes: sale of the OTC product line, signing a new development/marketing partner for Crinone 4% and announcing favorable P2 results for Chronodyne or the buccal testosterone tablets.